"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Penicilline","Ampicillina",2257,"86.7","85.2","88.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Aminoglicosidi (alto dosaggio)","Streptomicina",1683,"72.0","69.8","74.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Aminoglicosidi (alto dosaggio)","Gentamicina",1653,"57.0","54.5","59.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Glicopeptidi","Vancomicina",2291,"18.9","17.4","20.6"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Glicopeptidi","Teicoplanina",2280,"18.4","16.8","20.0"
